Stocks
Agios Pharmaceuticals (AGIO) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -334.9% | -160.5% | -2 672% | -1 435% | 2 137% | |||
| Changes by years, y/y, % | +49pp | +174pp | +160pp | +1 237pp | +30.2% | ||||
Agios Pharmaceuticals. EBITDA margin, %
Agios Pharmaceuticals. EBITDA margin, changes, pp
Agios Pharmaceuticals (AGIO) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | -1 342% | -1 476% | -1 108% | -1 210% | 11 182% | 2 137% | |
| Changes by years, y/y, % | +1 319pp | +3 749pp | +508pp | +186pp | +12 524pp | |||
| Changes by quarters, q/q, % | +54pp | -135pp | +369pp | -102pp | +12 392pp | |||
